Company**Location TechnologiesProducts/Disease FocusDevelopment Stage
Aeterna Labor-Ste-Foy, AngiogenesisPsoriasisPhase II
atories Inc.QuebecLung cancerPhase I
(TSE:AEL)
Allelix Bio-Mississauga,Protein therapeutics;OsteoporosisPhase II
pharmaceuticalsOntarioneuropharmaceuticalsMigrainePhase I
Inc. (TSE:AXB)Gastrointestinal disordersPhase I
AnorMED Inc.*Vancouver,Metal-based therapeuticsRadiopharmaceuticalsPhase III
BritishCancer therapiesPhase I
Columbia
Bioniche Inc.London;Immunostimulation;Bladder cancerPhase III
(TSE:BNE)Ontariohyaluronic acid
Cangene Corp.Winnipeg,Plasma products (hyper-AIDSPhase II
(TSE:CNJ)Manitobaimmune); recombinantGM-CSFPhase III
therapeuticsOral iron chelatorPhase III
GlycoDesign Inc.*Toronto,Glycoprotein-basedRenal cell carcinomaPhase II
OntariotherapeuticsColorectal cancerPhase II
Hemosol Inc.Etobicoke,Human therapeuticsBlood substitutePhase II
(TSE:HML)Ontario
IBEX Technologies Montreal,Neutralase for Cardiovascular diseasePhase III
Inc. (TSE:IBT)Quebecheparin reversal
Inex TechnologiesVancouver,Lipid-based drugChemotherapyPhase II
Inc. (TSE:IEX)British delivery systemGene therapy/antisensePre-clinical
Columbia
Nortran Pharma-Vancouver, Small molecule thera-AnesthesiaPhase II
ceuticals Inc.Britishpeutics for cardio-AntiarrhythmiaPhase I
(VSE:NRT)Columbiavascular drugs; pain
management
QLT Photo-Vancouver,Photodynamic therapyLung and esophagealOn market
Therapeutics Inc.Britishcancers
(TSE:QLT)Columbia
Synsorb BiotechCalgary,Carbohydrate-basedHemolytic uremicPhase III
Inc. (TSE:SYB)Albertagastroenteric productssyndrome
Vasogen Inc.Toronto,Patient-specific cellPeripheral vascularApproved
(ME:VAS)Ontariotherapiesdisease(Europe)
NOTES:
ME = Montreal Exchange; TSE = Toronto Stock Exchange; VSE= Vancouver Stock Exchange
* Private companies are indicated with an asterisk.

No Comments